ZilvEr PTX for tHe Femoral ArterY and Proximal Popliteal ArteRy. -Prospective multicenter registry-

ZilvEr PTX for tHe Femoral ArterY and Proximal Popliteal ArteRy. -Prospective multicenter registry- - ZEPHYR Registry

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000008433

Enrollment

1000

Registered

2012-07-13

Start date

2012-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peripheral artery disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Symptomatic patients with peripheral artery disease due to Femoro-popliteal arterial lesions

Exclusion criteria

Exclusion criteria: 1) life expectancy <1 yrs 2) unsuccessful angioplasty 3) residual inflow lesion 4) ALI 5) active bleeding 6) allergy for nitinol

Design outcomes

Primary

Measure	Time frame
One-year restenosis rates	—

Secondary

Measure	Time frame
1) All-cause mortality 2) CAD 3) MI 4) Stroke 5) Freedom from TVR 6) Surgical conversion rates 7) MLower-limb Major amputation rates 8) Technical complications of EVT 9) in-stent thrombosis 10) Bleeding complications	—

Countries

Japan

Contacts

Public ContactOsamu Iida

Kansai Rosai Hospital Cardiovascular Center

iida.osa@gmail.com06-6416-1221

Outcome results